Get started
Author

Cameron J. McKinzie

Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding
2018 · Aaron Trimble, Cameron McKinzie, et al. · Journal of Cystic Fibrosis · 83
PDF
Worsening anxiety and depression after initiation of lumacaftor/ivacaftor combination therapy in adolescent females with cystic fibrosis
2017 · Cameron J. McKinzie, Jennifer L. Goralski, et al. · Journal of Cystic Fibrosis · 67
Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit
2020 · Sara N. Salerno, Yuting Liao, et al. · The Journal of Pediatrics · 56
Cystic Fibrosis Foundation otolaryngology care multidisciplinary consensus recommendations
2022 · Adam J. Kimple, Brent A. Senior, et al. · International Forum of Allergy & Rhinology · 53
PDF
Changes in fecal elastase-1 following initiation of CFTR modulator therapy in pediatric patients with cystic fibrosis
2023 · Kimberly G. Stephenson, Abby J. Lingle, et al. · Journal of Cystic Fibrosis · 27
PDF
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients
2022 · Christina Teeter Doligalski, Cameron J. McKinzie, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 26
Use of elexacaftor/tezacaftor/ivacaftor in liver transplant patients with cystic fibrosis
2021 · Cameron J. McKinzie, Christina T. Doligalski, et al. · Journal of Cystic Fibrosis · 25
PDF
Elexacaftor/tezacaftor/ivacaftor treatment reduces airway inflammation in cystic fibrosis
2023 · Richard C. De Vuyst, Erin Bennard, et al. · Pediatric Pulmonology · 18
PDF
Cystic fibrosis airway inflammation enables elexacaftor/tezacaftor/ivacaftor-mediated rescue of N1303KCFTRmutation
2023 · Martina Gentzsch, Brooke Baker, et al. · ERJ Open Research · 16
PDF
Off‐label use of intravenous antimicrobials for inhalation in patients with cystic fibrosis
2019 · Cameron J. McKinzie, Lori Chen, et al. · Pediatric Pulmonology · 16
Novel therapies for treatment of resistant and refractory nontuberculous mycobacterial infections in patients with cystic fibrosis
2020 · Thomas W. Laudone, Lauren Garner, et al. · Pediatric Pulmonology · 14
PDF
Association of Medication Regimen Complexity With Clinical Endpoints in Pediatric Patients With Cystic Fibrosis
2021 · Shelby L. Tjugum, B. Kyle Hansen, et al. · The Journal of Pediatric Pharmacology and Therapeutics · 12
Development of an electronic trigger tool at a children’s hospital within an academic medical center
2019 · Megan Fortenberry, Johlee Odinet, et al. · American Journal of Health-System Pharmacy · 12
Use of inhaled imipenem/cilastatin in pediatric patients with cystic fibrosis: A case series
2019 · Lee Ann Jones, Lorna Doucette, et al. · Journal of Cystic Fibrosis · 12
PDF
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor
2024 · Richard De Vuyst, Charissa W. Kam, et al. · Pediatric Pulmonology · 11
PDF
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease
2023 · Sean McCann, Jaydeep Sinha, et al. · Clinical Pharmacokinetics · 10
PDF
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Microbiology and Antibiotic Utilization in People With Cystic Fibrosis
2025 · Cindy L. Williams, Joanna Billings, et al. · Pediatric Pulmonology · 8
PDF
Use of pirfenidone in pediatric patients with interstitial lung disease and pulmonary fibrosis
2023 · Cameron J. McKinzie, W. Adam Gower, et al. · Pediatric Pulmonology · 8
PDF
Outcomes of Children with Fetal and Lactation Immunosuppression Exposure Born to Female Transplant Recipients
2022 · Cameron J. McKinzie, Jillian P. Casale, et al. · Pediatric Drugs · 8
Evaluation of Posaconazole Dosing in Children and Young Adults: A Single-Center Review
2021 · Lauren M. Garner, Susan Ngo, et al. · The Journal of Pediatric Pharmacology and Therapeutics · 7
Use of telavancin in adolescent patients with cystic fibrosis and prior intolerance to vancomycin: A case series
2018 · Adam T. Bernstein, Margaret W. Leigh, et al. · Journal of Cystic Fibrosis · 7
Gilbert's syndrome leads to elevated bilirubin after initiation of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis
2024 · Nidhi Patel, Maria Ansar, et al. · Pediatric Pulmonology · 6
PDF
Continuous vancomycin in a pediatric cystic fibrosis patient
2017 · Cameron J. McKinzie, Charles R. Esther, et al. · Pediatric Pulmonology · 5
PDF
Severe mental health changes in patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor therapy
2024 · Cameron J. McKinzie, Stephanie R. Duehlmeyer, et al. · Pediatric Pulmonology · 4
Papilledema in Children With Cystic Fibrosis Receiving Elexacaftor/Tezacaftor/Ivacaftor: A Multicenter Case Series
2024 · Charissa W. Kam, Cameron J. McKinzie, et al. · Pediatric Pulmonology · 3
Works count: 59
Citation count: 524
H-index: 12
I10-index: 16
Year
Topic
Type